🔗 Share this article

An underground market for unlicensed weight-loss medications is being driven by social media fitness personalities and vendors on communication apps, based on new investigations.

Investigational Treatment Gaining Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its alleged weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also receiving promotional offers.

Thriving Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where groups with thousands of members share comparison photos, injection guides and claims of next-day British shipping. Vendors promote the substance there before redirecting buyers to WhatsApp for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug affects three intestinal hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help patients reduce up to 25% of their total weight. Referred to as the “triple G”, the drug is being promoted online as the next Ozempic.

Medical Experts Voice Worries

However, physicians and pharmacists have warned that the distribution of what remains an unapproved drug in the UK is a cause for concern and could result in individuals injecting products of unknown origin.

Several experts stated the popularity for the experimental drug could be connected to the rising price of approved weight loss treatments such as Mounjaro.

Regulatory Status and Implementation

Marketing retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be marketed or distributed for personal consumption under the British medical regulations.

Some influencers attempt to circumvent the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, marketing, and customer laws, risking penalties, prosecution or imprisonment.

Platform Response and Material Removal

Based on the social media company, the platform has removed problematic content and prohibited related hashtags and search suggestions. The organization stated it was committed to maintaining the platform secure and investing in strengthening enforcement strategies.

Online Trading Activities

Investigations also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly brings up groups with numerous of members, populated with images of slimming results, glowing testimonials and detailed guides for preparing or injecting at home.

Within moments of entering one community, a seller posted contact information, where the majority of purchases take place. The seller sent an instruction manual and promised delivery within two days. When questioned whether the product was genuine, one seller said: “You can’t be sure.” Another shared a image of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Details and Pricing

Inside these communities, posts display dark colored parcels with postal service labels, stating to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Buyers can select between dry substance containers, mixed at residence with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how much time a pen should last, vendors give conflicting responses ranging from a few weeks to “depends on your body”.

Service Oversight and Security Measures

A spokesperson for the messaging service said it regularly monitored dangerous material on its service including content that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.

Medical Expert Warnings

“People are injecting materials they can’t verify. Although the science behind retatrutide is valid, these digital products may not contain what they advertise,” stated Jason Murphy, the head of pharmaceutical services at a pharmacy service.

Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved slimming drugs such as Mounjaro. “With prices increasing, individuals are using online platforms. But fake injections are extremely risky. You cannot know what’s inside or whether the environment they were made in was sterile,” she said.

Her staff has already encountered patients injured by personal administration from unconfirmed suppliers. “We recognize the disappointment, but purchasing from messaging apps or WhatsApp is taking chances with your health,” said Wyllie. “These substances could be impure or improperly measured.”

Manufacturer Position

A spokesperson from Eli Lilly stated the substance was in third stage clinical trials and had not been reviewed or approved by any regulatory agency globally. “Consequently at this point no one can market [it] for human use,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may subject patients to potentially significant medical dangers”.